Yolanda Munoz Maldonado

Yolanda Munoz Maldonado

Auto-generated profile, based on publicly available information

Yolanda Munoz Maldonado

CorEvitas, LLC, Waltham, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in JACC
Verified
Journal Article
Closed access
SNSherif F. Nagueh
Sherif F. Nagueh
BGBertron M. Groves
Bertron M. Groves
LSLeonard Schwartz
Leonard Schwartz
KSKaren M. Smith
Karen M. Smith
AWAndrew Wang
Andrew Wang
WSWilliam H. Spencer
William H. Spencer

1 December 2015 in The American Journal of Surgery
Verified
Journal Article
Closed access
JRJustin L. Regner
Justin L. Regner
MMMary M. Mrdutt
Mary M. Mrdutt
YMYolanda Munoz-Maldonado
Yolanda Munoz-Maldonado

15 July 2004 in Journal of the Royal Statistical Society Series B: Statistical Methodology
Verified
Journal Article
Closed access
PDF file
RER. L. Eubank
R. L. Eubank
CHChunfeng Huang
Chunfeng Huang
YMY. Muñoz Maldonado
Y. Muñoz Maldonado
NWNaisyin Wang
Naisyin Wang
SWSuojin Wang
Suojin Wang
RBR. J. Buchanan
R. J. Buchanan

1 April 2017 in Journal of Orthopaedic & Sports Physical Therapy
Verified
Journal Article
Closed access
KBKindyle L. Brennan
Kindyle L. Brennan
BABryce C. Allen
Bryce C. Allen
YMYolanda Munoz Maldonado
Yolanda Munoz Maldonado
Study Design: Prospective, randomized, partially blinded. Background: Greater trochanteric pain syndrome (GTPS) is the current terminology for what was once called greater trochanteric or subgluteal bursitis. Cortisone (corticosteroid) injection into the lateral hip has traditionally been the accepted treatment for this condition; however, the effectiveness of injecting the bursa with steroids is increasingly being questioned. An equally effective treatment with fewer adverse side effects would be beneficial. Objective: To investigate whether administration of dry needling (DN) is noninferior to cortisone injection in reducing lateral hip pain and improving function in patients with GTPS. Methods: Forty-three participants (50 hips observed), all with GTPS, were randomly assigned to a group receiving cortisone injection or DN. Treatments were administered over 6 weeks, and clinical outcomes were collected at baseline and at 1, 3, and 6 weeks. The primary outcome measure was the numeric pain-rating scale (0–10). The secondary outcome measure was the Patient-Specific Functional Scale (0–10). Medication intake for pain was collected as a tertiary outcome. Results: Baseline characteristics were similar between groups. A noninferiority test for a repeated-measures design for pain and averaged function scores at 6 weeks (with a noninferiority margin of 1.5 for both outcomes) indicated noninferiority of DN versus cortisone injection (both, P<.01). Medication usage (P = .74) was not different between groups at the same time point. No adverse side effects were reported. Conclusion: Cortisone injections for GTPS did not provide greater pain relief or reduction in functional limitations than DN. Our data suggest that DN is a noninferior treatment alternative to cortisone injections in this patient population. Level of Evidence: Therapy, level 1b. Registered December 2, 2015 at www.clinicaltrials.gov (NCT02639039). J Orthop Sports Phys Ther 2017;47(4):232–239. Epub 3 Mar 2017. doi:10.2519/jospt.2017.6994

1 October 2016 in Surgery
Verified
Journal Article
Closed access
CHChad M. Hall
Chad M. Hall
SSSamuel K. Snyder
Samuel K. Snyder
YMYolanda Muñoz Maldonado
Yolanda Muñoz Maldonado
TLTerry C. Lairmore
Terry C. Lairmore